Mithradote Bio is a biotechnology company developing a novel medication to help prevent drug-facilitated sexual assault.
Mithradote Bio has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Mithradote Bio's investors include Vickers Venture Partners, Taho Pharmaceuticals.
Mithradote Bio is headquartered in San Diego, United States.
Mithradote Bio is a biotechnology company developing a novel medication to help prevent drug-facilitated sexual assault.
Mithradote Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mithradote Bio — Funding & Investors." VCBacked, October 2, 2024, https://www.vcbacked.co/company/mithradote-bio. Accessed October 30, 2026.
VCBacked. (2024). Mithradote Bio — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/mithradote-bio
{{cite web |title=Mithradote Bio — Funding & Investors |url=https://www.vcbacked.co/company/mithradote-bio |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated